In one paragraphArticle in Cells, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from itWhat it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
10 authors.
Aksinya N UvarovaEngelhardt Institute of Molecular Biology, Russian Academy of Sciences, 119991 Moscow, Russia.ORCID 0000-0002-3168-6872 Lidia V PutlyaevaCenter for Regenerative Medicine, Medical Research and Educational Institute, Lomonosov Moscow State University, 119234 Moscow, Russia.ORCID 0000-0003-0684-5672 Kirill V KorneevEngelhardt Institute of Molecular Biology, Russian Academy of Sciences, 119991 Moscow, Russia.ORCID 0000-0003-3570-8327 Ekaterina M StasevichEngelhardt Institute of Molecular Biology, Russian Academy of Sciences, 119991 Moscow, Russia.ORCID 0000-0003-2150-9458 Elvina A PrikhodkoEngelhardt Institute of Molecular Biology, Russian Academy of Sciences, 119991 Moscow, Russia.ORCID 0009-0009-9407-613X Matvey M MurashkoEngelhardt Institute of Molecular Biology, Russian Academy of Sciences, 119991 Moscow, Russia.ORCID 0000-0001-7235-5052 Denis E DeminEngelhardt Institute of Molecular Biology, Russian Academy of Sciences, 119991 Moscow, Russia.ORCID 0000-0002-5553-6588 Elina A ZheremyanEngelhardt Institute of Molecular Biology, Russian Academy of Sciences, 119991 Moscow, Russia.ORCID 0000-0002-1230-6168 Anton M SchwartzDepartment of Human Biology, Faculty of Natural Sciences, University of Haifa, Haifa 3498838, Israel.
Dmitry V KuprashEngelhardt Institute of Molecular Biology, Russian Academy of Sciences, 119991 Moscow, Russia.ORCID 0000-0002-1488-4148 Funding
Ministry of Science and Higher Education of the Russian Federation No. 075-15-2025-519Russian Science Foundation 14-14-01140Russian Science Foundation 19-14-00341
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
AllelesB-LymphocytesGenes, ReporterLupus Erythematosus, SystemicNucleotide MotifsPolymorphism, Single NucleotidePromoter Regions, GeneticProto-Oncogene Proteins c-mycSignaling Lymphocytic Activation Molecule Family Member 1Genetic Predisposition to DiseaseHumansProto-Oncogene Proteins c-mycSignaling Lymphocytic Activation Molecule Family Member 1SLAMF1 protein, humanallele-specific regulationB cellsCD150c-MYCrs2295613rs2295614SLAMF1SLESNP
Identifiers
PMID42738862
PMCPMC13565327
What OpenQuestion holds
Textmetadata
Read underepoch 390